Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ·Healthcare·Biotechnology
$2.13
-6.58%
Mkt Cap $163.55M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+228.6%
Consensus $7.00 vs current $2.13
NASDAQ·Healthcare·Biotechnology
$2.13
-6.58%
Mkt Cap $163.55M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
+228.6%
Consensus $7.00 vs current $2.13